Global Zyprexa Senior Brand Strategy Director Continued (2002-2004)
Responsible for global brand management and all new indication launches. Led strategy development and implementation for 3rd largest pharmaceutical brand in the world, resulting in sales growth from $3.6 to $4.4 billion.
Led, managed and developed team of 1 brand manager and 7 associate brand managers.
Championed mid-life cycle patient segmentation, re-positioning and integrated marketing mix management, resulting in stabilizing HCPs, “intent to prescribe,” following global label changes
Responsible for ensuring affiliates buy-in and alignment to global strategy and marketing communication plan globally.
Led relationship with global medical advertising and public relations agencies resulting in mutual, highly valued relationship.
US Diabetes Care Brand Director (1999-2001)
Managed $900 million device and pharmaceutical portfolio, with 10% share growth in meal-time market.
Led product launch for Humalog Mix 75/25 Pen, delivering 58M in first year of launch.
Developed segmentation, positioning, disease state and product launch campaigns for physician, consumer and payers.
Planned and executed launch meeting for 1000+ representatives.
Led partnership with medical and consumer advertising agencies.